BactiTox A/S
CVR number: 39423545
Nyholms Alle 40, 2610 Rødovre
vs@bactitox.com
tel: 22579020
bactitox.com
Income statement (kDKK)
2019 | 2020 | 2021 | 2022 | 2023 | |
---|---|---|---|---|---|
Fiscal period length | 12 | 12 | 12 | 12 | 12 |
Net sales | |||||
Gross profit | 331.76 | 9 194.36 | 7 142.52 | 23 746.79 | - 841.28 |
Employee benefit expenses | -0.45 | - 181.00 | -2 917.00 | -1 954.10 | -1 190.38 |
Other operating expenses | - 278.47 | - 233.00 | |||
Total depreciation | -1 069.62 | - 178.85 | - 182.42 | - 182.42 | |
EBIT | 331.31 | 7 943.75 | 3 768.20 | 21 377.27 | -2 214.08 |
Other financial income | 3.98 | 7.80 | |||
Other financial expenses | -3.39 | -25.06 | - 379.66 | - 150.94 | -19.80 |
Pre-tax profit | 327.92 | 7 922.67 | 3 388.55 | 21 226.33 | -2 226.09 |
Income taxes | -72.16 | -1 750.30 | -1 049.41 | -4 731.91 | 545.57 |
Net earnings | 255.76 | 6 172.37 | 2 339.14 | 16 494.42 | -1 680.52 |
Assets (kDKK)
2019 | 2020 | 2021 | 2022 | 2023 | |
---|---|---|---|---|---|
Intangible assets total | |||||
Buildings | 1 051.66 | 988.49 | 865.68 | ||
Machinery and equipment | 278.47 | 888.00 | 119.20 | 59.60 | |
Tangible assets total | 278.47 | 1 939.66 | 1 107.69 | 925.28 | |
Investments total | |||||
Long term receivables total | |||||
Finished products/goods | 885.07 | 263.43 | 413.43 | 413.43 | |
Inventories total | 885.07 | 263.43 | 413.43 | 413.43 | |
Current trade debtors | 9.38 | 2 402.90 | 1 815.62 | 3 817.05 | 566.37 |
Current amounts owed by group member comp. | 494.02 | 9 495.75 | 8 096.59 | 149.50 | |
Current other receivables | 27.39 | 43.64 | 95.80 | 345.96 | 61.57 |
Current deferred tax assets | 545.57 | ||||
Short term receivables total | 530.79 | 11 942.29 | 10 008.01 | 4 312.50 | 1 173.51 |
Cash and bank deposits | 399.82 | 433.43 | 176.04 | ||
Cash and cash equivalents | 399.82 | 433.43 | 176.04 | ||
Balance sheet total (assets) | 530.79 | 13 105.83 | 12 610.92 | 6 267.06 | 2 688.25 |
Equity and liabilities (kDKK)
2019 | 2020 | 2021 | 2022 | 2023 | |
---|---|---|---|---|---|
Share capital | 2.00 | 400.00 | 400.00 | 400.00 | 400.00 |
Shares repurchased | 24 819.91 | ||||
Other reserves | 38.00 | -24 819.91 | |||
Retained earnings | -51.08 | - 155.31 | 6 017.06 | -16 463.71 | 30.71 |
Profit of the financial year | 255.76 | 6 172.37 | 2 339.14 | 16 494.42 | -1 680.52 |
Shareholders equity total | 244.69 | 6 417.06 | 8 756.20 | 430.71 | -1 249.81 |
Provisions | 3.83 | ||||
Non-current deferred tax liabilities | 84.15 | ||||
Non-current liabilities total | 84.15 | ||||
Current trade creditors | 10.00 | 1 105.76 | 2 011.44 | 827.88 | 351.91 |
Current owed to group member | 84.15 | 99.41 | 3 465.06 | ||
Short-term deferred tax liabilities | 1 738.64 | 835.03 | 4 731.91 | ||
Other non-interest bearing current liabilities | 191.95 | 3 756.39 | 1 008.25 | 177.15 | 121.09 |
Current liabilities total | 201.95 | 6 684.94 | 3 854.72 | 5 836.35 | 3 938.06 |
Balance sheet total (liabilities) | 530.79 | 13 105.83 | 12 610.92 | 6 267.06 | 2 688.25 |
Try the full version of our system for free
Create your own estimates for any company
Valuation analysis
See instructions
... and more!
No registration needed.